Triglycerides and coronary heart disease: have recent insights yielded conclusive answers?

被引:15
作者
Sarwar, Nadeem [1 ]
Sattar, Naveed [2 ]
机构
[1] Univ Aberdeen, Sect Populat Hlth, Aberdeen AB25 2ZD, Scotland
[2] Univ Glasgow, Fac Med, Div Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland
基金
英国医学研究理事会;
关键词
coronary heart disease; lipid; triglyceride; DENSITY-LIPOPROTEIN CHOLESTEROL; NONFASTING TRIGLYCERIDES; REGRESSION DILUTION; RISK-FACTORS; CARDIOVASCULAR RISK; MENDELIAN RANDOMIZATION; RICH LIPOPROTEINS; BLOOD-PRESSURE; FATTY-ACIDS; UNDERESTIMATION;
D O I
10.1097/MOL.0b013e32832dd4dc
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purpose of review Despite over 50 years of research, the relevance of triglycerides to coronary heart disease risk remains uncertain. Recent findings Contrary to prevailing views, recent studies demonstrate that the long-term within-individual variability of triglyceride measurements is similar to that of other lipid fractions. Several prospective studies have reported on associations of circulating triglyceride levels with coronary heart disease risk, but it remains unclear whether observed associations are dependent on levels of conventional risk factors (especially other lipids) or are importantly modified under different circumstances (especially by fasting status). Ongoing large-scale studies should help clarify such outstanding uncertainties and assess whether measurement of triglyceride levels can better identify individuals at increased risk of coronary heart disease than measurement of conventional risk factors alone. Available interventions that lower levels of triglycerides are unable to judge causality as such interventions typically influence levels of several lipid fractions. Study of genetic variants that regulate triglyceride levels may provide an alternative approach to assess causality. Summary Although recent studies have progressed our understanding of triglycerides and coronary heart disease, several outstanding uncertainties remain unresolved. Ongoing studies should help clarify these, including whether measurement of triglyceride levels can help improve coronary heart disease risk assessment, and study of genetic variants may help better understand any causal role.
引用
收藏
页码:275 / 281
页数:7
相关论文
共 52 条
[1]  
Ahmad I, 2000, J CARDIOVASC RISK, V7, P303
[2]   SERUM TRIGLYCERIDES IN CORONARY ARTERY DISEASE [J].
ALBRINK, MJ ;
MAN, EB .
ARCHIVES OF INTERNAL MEDICINE, 1959, 103 (01) :4-8
[3]   The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases [J].
不详 .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2007, 22 (12) :839-869
[4]   Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women [J].
Bansal, Sandeep ;
Buring, Julie E. ;
Rifai, Nader ;
Mora, Samia ;
Sacks, Frank M. ;
Ridker, Paul M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (03) :309-316
[5]   The physiological and molecular regulation of lipoprotein assembly and secretion [J].
Blasiole, Daniel A. ;
Davis, Roger A. ;
Attie, Alan D. .
MOLECULAR BIOSYSTEMS, 2007, 3 (09) :608-619
[6]   Fish oil and secondary prevention of cardiovascular disease [J].
Brunner, Eric ;
Iso, Hiroyasu .
BRITISH MEDICAL JOURNAL, 2008, 337
[7]  
Carroll R., 1995, MEASUREMENT ERROR NO
[8]   Risk factors, ethnic differences and mortality associated with lower-extremity gangrene and amputation in diabetes. The WHO multinational study of vascular disease in diabetes [J].
Chaturvedi, N ;
Stevens, LK ;
Fuller, JH ;
Lee, ET ;
Lu, M .
DIABETOLOGIA, 2001, 44 (Suppl 2) :S65-S71
[9]  
Clarke R, 1999, AM J EPIDEMIOL, V150, P341
[10]   Postprandial lipemia and remnant lipoproteins [J].
Cohn, Jeffrey S. .
CLINICS IN LABORATORY MEDICINE, 2006, 26 (04) :773-+